GANSID Conference 2026
The GANSID Congress 2026 is a global gathering, bringing together clinicians, researchers, laboratory and/or translational scientists, patient organizations, industry partners, policymakers, and global health agencies.
Building on the success of previous virtual congresses, the GANSID Congress 2026 is the1st in-person Congress of the GANSID, offering a unique cross-disease platform focused on inherited blood disorders.
The 2026 Congress will focus on key scientific and health system priorities, including:
Emerging therapies and curative approaches, including gene and cellular therapies
Advances in transfusion medicine and comprehensive care
Implementation science and health system integration in low- and middle-income countries
Patient-centred outcomes, quality of life, and community engagement.
The Congress runs from Friday, 23 October to Sunday, 25 October inclusive and is being held in Hyderabad, India. Here is a link to the agenda.
Alejandra Watson (our President) and Carl Lander (Research Director) are members of the Congress Scientific Committee and have both been invited to present lectures. Alejandra will be speaking about transition (particularly as people age), and Carl will be speaking about novel PK Deficiency therapies, including gene therapy.
Further updates will follow on this page.